Free Trial

Venus Concept (VERO) Competitors

Venus Concept logo
$2.62 -0.11 (-4.03%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$2.70 +0.09 (+3.24%)
As of 07/11/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VERO vs. MHUA, INBS, LYRA, DHAI, WOK, PAVM, SSKN, NURO, CODX, and BTCY

Should you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include Meihua International Medical Technologies (MHUA), Intelligent Bio Solutions (INBS), Lyra Therapeutics (LYRA), DIH Holding US (DHAI), WORK Medical Technology Group (WOK), PAVmed (PAVM), Strata Skin Sciences (SSKN), NeuroMetrix (NURO), Co-Diagnostics (CODX), and Biotricity (BTCY). These companies are all part of the "medical equipment" industry.

Venus Concept vs. Its Competitors

Venus Concept (NASDAQ:VERO) and Meihua International Medical Technologies (NASDAQ:MHUA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, analyst recommendations, dividends, valuation and profitability.

Meihua International Medical Technologies has higher revenue and earnings than Venus Concept.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Venus Concept$64.83M0.06-$47M-$76.30-0.03
Meihua International Medical Technologies$96.90M0.16$10.84MN/AN/A

Venus Concept has a beta of 0.07, meaning that its share price is 93% less volatile than the S&P 500. Comparatively, Meihua International Medical Technologies has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500.

87.4% of Venus Concept shares are owned by institutional investors. Comparatively, 1.2% of Meihua International Medical Technologies shares are owned by institutional investors. 28.0% of Venus Concept shares are owned by company insiders. Comparatively, 66.6% of Meihua International Medical Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Meihua International Medical Technologies has a net margin of 0.00% compared to Venus Concept's net margin of -81.26%. Meihua International Medical Technologies' return on equity of 0.00% beat Venus Concept's return on equity.

Company Net Margins Return on Equity Return on Assets
Venus Concept-81.26% -752.29% -54.52%
Meihua International Medical Technologies N/A N/A N/A

In the previous week, Venus Concept had 2 more articles in the media than Meihua International Medical Technologies. MarketBeat recorded 3 mentions for Venus Concept and 1 mentions for Meihua International Medical Technologies. Meihua International Medical Technologies' average media sentiment score of 1.31 beat Venus Concept's score of 0.87 indicating that Meihua International Medical Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
Venus Concept Positive
Meihua International Medical Technologies Positive

Summary

Meihua International Medical Technologies beats Venus Concept on 9 of the 11 factors compared between the two stocks.

Get Venus Concept News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VERO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VERO vs. The Competition

MetricVenus ConceptMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$3.89M$6.82B$5.62B$9.10B
Dividend YieldN/A1.25%5.24%4.00%
P/E Ratio-0.0324.8928.0020.27
Price / Sales0.0649.57429.5999.28
Price / CashN/A20.9237.4658.16
Price / Book0.614.648.045.49
Net Income-$47M$174.76M$3.18B$250.45M
7 Day Performance0.19%-1.00%3.60%4.73%
1 Month Performance2.34%-1.49%4.00%7.61%
1 Year Performance-61.58%4.27%29.52%16.39%

Venus Concept Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VERO
Venus Concept
0.7261 of 5 stars
$2.62
-4.0%
N/A-62.8%$3.89M$64.83M-0.03410Gap Up
MHUA
Meihua International Medical Technologies
1.2453 of 5 stars
$0.41
-5.3%
N/A-49.5%$13.96M$96.91M0.00620Positive News
INBS
Intelligent Bio Solutions
0.8391 of 5 stars
$1.70
-4.5%
N/A-5.9%$12.30M$2.94M0.0010
LYRA
Lyra Therapeutics
2.3944 of 5 stars
$9.03
+0.3%
$100.00
+1,007.4%
-40.8%$11.93M$1.53M-0.1550
DHAI
DIH Holding US
0.6684 of 5 stars
$0.25
+5.2%
N/A-92.2%$11.08M$64.47M-0.82N/AGap Down
WOK
WORK Medical Technology Group
N/A$0.71
+0.1%
N/AN/A$10.36M$11.51M0.00226Gap Down
PAVM
PAVmed
4.4148 of 5 stars
$0.59
-1.2%
$19.00
+3,120.3%
-29.7%$10.21M$2.99M0.8390Positive News
SSKN
Strata Skin Sciences
3.3715 of 5 stars
$2.38
+2.1%
$6.00
+152.1%
-21.5%$9.72M$33.62M-1.05120High Trading Volume
NURO
NeuroMetrix
N/A$4.55
+4.4%
N/A+24.7%$9.37M$3.03M-0.9920High Trading Volume
CODX
Co-Diagnostics
4.2455 of 5 stars
$0.26
-5.8%
$5.50
+2,007.3%
-80.8%$9.30M$3.91M-0.22100
BTCY
Biotricity
N/A$0.36
-14.3%
N/A-57.2%$8.97M$12.06M-0.3340Gap Up

Related Companies and Tools


This page (NASDAQ:VERO) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners